Introduction to metabolomics and its applications in ophthalmology

Eye (Basingstoke)

Volumn 30, Issue 6, 2016, Pages 773-783

  Tan, S Z ^a,b   Begley, P ^a,c   Mullard, G ^a,c   Hollywood, K A ^a,b,c   Bishop, P N ^a,b,c  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ANALYTICAL EQUIPMENT; DATA ANALYSIS; DRUG DEVELOPMENT; EVALUATION STUDY; HUMAN; LIQUID; MEDICAL RESEARCH; METABOLIC DISORDER; METABOLITE; METABOLOME; METABOLOMICS; NONHUMAN; OPHTHALMOLOGY; PATHOGENESIS; REVIEW; RISK FACTOR; TISSUE METABOLISM; WORKFLOW; ANIMAL; PROCEDURES;

ANIMALS; BIOMARKERS; BIOMEDICAL RESEARCH; HUMANS; METABOLOMICS; OPHTHALMOLOGY;

EID: 85015989455     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2016.37     Document Type: Review

References (74)

1. Dunn WB, Broadhurst DI, Atherton HJ, Goodacre R, Griffin JL. Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy. Chem Soc Rev 2011; 40(1): 387-426.
2. Dunn WB, Broadhurst D, Begley P, Zelena E, Francis-McIntyre S, Anderson N et al. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat Protoc 2011; 6(7): 1060-1083.
3. Oliver SG, Winson MK, Kell DB, Baganz F. Systematic functional analysis of the yeast genome. Trends Biotechnol 1998; 16(9): 373-378.
4. Ellis DI, Dunn WB, Griffin JL, Allwood JW, Goodacre R. Metabolic fingerprinting as a diagnostic tool. Pharmacogenomics 2007; 8(9): 1243-1266.
5. Goodacre R, Vaidyanathan S, Dunn WB, Harrigan GG, Kell DB. Metabolomics by numbers: acquiring and understanding global metabolite data. Trends Biotechnol 2004; 22(5): 245-252.
6. Brown M, Wedge DC, Goodacre R, Kell DB, Baker PN, Kenny LC et al. Automated workflows for accurate massbased putative metabolite identification in LC/MS-derived metabolomic datasets. Bioinformatics 2011; 27(8): 1108-1112.
7. Kell DB, Oliver SG. Here is the evidence, now what is the hypothesis? The complementary roles of inductive and hypothesis-driven science in the post-genomic era. Bioessays 2004; 26(1): 99-105.
8. Broadhurst DI, Kell DB. Statistical strategies for avoiding false discoveries in metabolomics and related experiments. Metabolomics 2006; 2(4): 171-196.
9. Villas-Bôas SG, Roessner U, Hansen MAE, Smedsgaard J, Nielsen J (eds). Metabolome Analysis: An Introduction. Wiley Interscience John Wiley & Sons, Inc: USA, 2007.
10. Lu W, Bennett BD, Rabinowitz JD. Analytical strategies for LC-MS-based targeted metabolomics. J Chromatogr B Analyt Technol Biomed Life Sci 2008; 871(2): 236-242.
11. Dettmer K, Aronov PA, Hammock BD. Mass spectrometrybased metabolomics. Mass Spectrom Rev 2007; 26(1): 51-78.
12. Villas-Bôas SG, Mas S, Akesson M, Smedsgaard J, Nielsen J. Mass spectrometry in metabolome analysis. Mass Spectrom Rev 2005; 24(5): 613-646.
13. Dunn WB. Current trends and future requirements for the mass spectrometric investigation of microbial, mammalian and plant metabolomes. Phys Biol 2008; 5(1): 011001.
14. Moestue S, Sitter B, Bathen TF, Tessem MB, Gribbestad IS. HR MAS MR spectroscopy in metabolic characterization of cancer. Curr Top Med Chem 2011; 11(1): 2-26.
15. Midelfart A. Metabonomics-a new approach in ophthalmology. Acta Ophthalmol 2009; 87(7): 697-703.
16. Alia A, Ganapathy S, de Groot HJ. Magic Angle Spinning (MAS) NMR: a new tool to study the spatial and electronic structure of photosynthetic complexes. Photosynth Res 2009; 102(2-3): 415-425.
17. Kryczka T, Wylȩgała E, Dobrowolski D, Midelfart A. NMR spectroscopy of human eye tissues: a new insight into ocular biochemistry. Scientific World J 2014; 2014: 546192.
18. Johnson CH, Gonzalez FJ. Challenges and opportunities of metabolomics. J Cell Physiol 2012; 227(8): 2975-2981.
19. HH. Analysis of a complex of statistical variables into principal components. J Educ Psychol 1933; 24: 417-441.
20. Young SP, Wallace GR. Metabolomic analysis of human disease and its application to the eye. J Ocul Biol Dis Infor 2009; 2(4): 235-242.
21. Go EP. Database resources in metabolomics: an overview. J Neuroimmune Pharmacol 2010; 5(1): 18-30.
22. Brown M, Dunn WB, Dobson P, Patel Y, Winder CL, Francis-McIntyre S et al. Mass spectrometry tools and metabolite-specific databases for molecular identification in metabolomics. Analyst 2009; 134(7): 1322-1332.
23. Jenkins H, Hardy N, Beckmann M, Draper J, Smith AR, Taylor J et al. A proposed framework for the description of plant metabolomics experiments and their results. Nat Biotechnol 2004; 22(12): 1601-1606.
24. Bino RJ, Hall RD, Fiehn O, Kopka J, Saito K, Draper J et al. Potential of metabolomics as a functional genomics tool. Trends Plant Sci 2004; 9(9): 418-425.
25. Midelfart A, Dybdahl A, Gribbestad IS. Metabolic analysis of the rabbit cornea by proton nuclear magnetic resonance spectroscopy. Ophthalmic Res 1996; 28(5): 319-329.
26. Midelfart A, Dybdahl A, Gribbestad S. Detection of different metabolites in the rabbit lens by high resolution 1H NMR spectroscopy. Curr Eye Res 1996; 15(12): 1175-1181.
27. Locci E, Scano P, Rosa MF, Nioi M, Noto A, Atzori L et al. A metabolomic approach to animal vitreous humor topographical composition: a pilot study. PLoS One 2014; 9(5): e97773.
28. Chen L, Zhou L, Chan EC, Neo J, Beuerman RW. Characterization of the human tear metabolome by LC-MS/MS. J Proteome Res 2011; 10(10): 4876-4882.
29. Karamichos D, Hutcheon AE, Rich CB, Trinkaus-Randall V, Asara JM, Zieske JD. In vitro model suggests oxidative stress involved in keratoconus disease. Sci Rep 2014; 4: 4608.
30. Mains J, Tan LE, Zhang T, Young L, Shi R, Wilson C. Species variation in small molecule components of animal vitreous. Invest Ophthalmol Vis Sci 2012; 53(8): 4778-4786.
31. Greiner JV, Lass JH, Glonek T. Metabolic status of fresh v eye-bank-processed corneas. A phosphorus nuclear magnetic resonance study. Arch Ophthalmol 1984; 102(11): 1676-1677.
32. Lass JH, Greiner JV, Medcalf SK, Kralik MR, Meneses P, Glonek T. Effects of moist-chamber and McCarey-Kaufman medium storage on the metabolic status of the cornea: a 31P-magnetic resonance analysis. Ophthalmic Res 1988; 20(6): 368-375.
33. Hayashi K, Cheng HM, Iwasaki M, Hua X, Kenyon KR. Metabolic analysis of reepithelializing rabbit cornea using p-31 nuclear magnetic-resonance spectroscopy. Graefes Arch Clin Exp Ophthalmol 1990; 228(1): 73-77.
34. Lass JH, Greiner JV, Merchant TE, Glonek T. The effects of age on phosphatic metabolites of the human cornea. Cornea 1995; 14(1): 89-94.
35. Gottsch JD, Chen CH, Stark WJ, Maumenee AE. Corneal metabolism monitored with NMR spectroscopy. Trans Am Ophthalmol Soc 1986; 84: 183-191.
36. Gottsch JD, Chen CH, Aguayo JB, Cousins JP, Strahlman ER, Stark WJ. Glycolytic activity in the human cornea monitored with nuclear magnetic resonance spectroscopy. Arch Ophthalmol 1986; 104(6): 886-889.
37. Aguayo JB, McLennan IJ, Graham Jr C, Cheng HM. Dynamic monitoring of corneal carbohydrate metabolism using highresolution deuterium NMR spectroscopy. Exp Eye Res 1988; 47(2): 337-343.
38. Fris M, Midelfart A. Postnatal biochemical changes in rat lens: an important factor in cataract models. Curr Eye Res 2007; 32(2): 95-103.
39. Lal S, Szwergold BS, Taylor AH, Randall WC, Kappler F, Brown TR. Production of fructose and fructose-3-phosphate in maturing rat lenses. Invest Ophthalmol Vis Sci 1995; 36(5): 969-973.
40. Tsentalovich YP, Verkhovod TD, Yanshole VV, Kiryutin AS, Yanshole LV, Fursova AZh et al. Metabolomic composition of normal aged and cataractous human lenses. Exp Eye Res 2015; 134: 15-23.
41. Tessem MB, Bathen TF, Cejkova J, Midelfart A. Effect of UV-A and UV-B irradiation on the metabolic profile of aqueous humor in rabbits analyzed by 1H NMR spectroscopy. Invest Ophthalmol Vis Sci 2005; 46(3): 776-781.
42. Risa O, Saether O, Lofgren S, Soderberg PG, Krane J, Midelfart A. Metabolic changes in rat lens after in vivo exposure to ultraviolet irradiation: measurements by high resolution MAS 1H NMR spectroscopy. Invest Ophthalmol Vis Sci 2004; 45(6): 1916-1921.
43. Huxtable RJ. Taurine in the central nervous system and the mammalian actions of taurine. Prog Neurobiol 1989; 32(6): 471-533.
44. Shioda R, Reinach PS, Hisatsune T, Miyamoto Y. Osmosensitive taurine transporter expression and activity in human corneal epithelial cells. Invest Ophthalmol Vis Sci 2002; 43(9): 2916-2922.
45. Rose RC, Bode AM. Ocular ascorbate transport and metabolism. Comp Biochem Physiol A Comp Physiol 1991; 100(2): 273-285.
46. van Heyningen R. What happens to the human lens in cataract. Sci Am 1975; 2336: 70-72; 77-81.
47. Podskochy A, Gan L, Fagerholm P. Apoptosis in UV-exposed rabbit corneas. Cornea 2000; 19(1): 99-103.
48. Hightower K, McCready J. Physiological effects of UVB irradiation on cultured rabbit lens. Invest Ophthalmol Vis Sci 1992; 33(5): 1783-1787.
49. Blankenberg FG, Katsikis PD, Storrs RW, Beaulieu C, Spielman D, Chen JY et al. Quantitative analysis of apoptotic cell death using proton nuclear magnetic resonance spectroscopy. Blood 1997; 89(10): 3778-3786.
50. Brubaker RF, Bourne WM, Bachman LA, McLaren JW. Ascorbic acid content of human corneal epithelium. Invest Ophthalmol Vis Sci 2000; 41(7): 1681-1683.
51. Saether O, Krane J, Risa O, Cejkova J, Midelfart A. High-resolution MAS 1H NMR spectroscopic analysis of rabbit cornea after treatment with dexamethasone and exposure to UV-B radiation. Curr Eye Res 2005; 30(12): 1041-1049.
52. Tsubota K, Kenyon KR, Cheng HM. Hard contact lens-induced metabolic changes in rabbit corneas. Exp Eye Res 1989; 49(5): 769-775.
53. Risa O, Saether O, Midelfart A, Krane J, Cejkova J. Analysis of immediate changes of water-soluble metabolites in alkali-burned rabbit cornea, aqueous humor and lens by high-resolution 1H-NMR spectroscopy. Graefes Arch Clin Exp Ophthalmol 2002; 240(1): 49-55.
54. Levinson RA, Paterson CA, Pfister RR. Ascorbic acid prevents corneal ulceration and perforation following experimental alkali burns. Invest Ophthalmol 1976; 15(12): 986-993.
55. Pfister RR, Hayes SA, Paterson CA. The influence of parenteral ascorbate on the strength of corneal wounds. Invest Ophthalmol Vis Sci 1981; 21(1 Pt 1): 80-86.
56. Pfister RR. Chemical injuries of the eye. Ophthalmology 1983; 90(10): 1246-1253.
57. Karamichos D, Zieske JD, Sejersen H, Sarker-Nag A, Asara JM, Hjortdal J. Tear metabolite changes in keratoconus. Exp Eye Res 2015; 132: 1-8.
58. Mayordomo-Febrer A, López-Murcia M, Morales-Tatay JM, Monleón-Salvado D, Pinazo-Durán MD. Metabolomics of the aqueous humor in the rat glaucoma model induced by a series of intracamerular sodium hyaluronate injection. Exp Eye Res 2015; 131: 84-92.
59. Dreyer EB, Zurakowski D, Schumer RA, Podos SM, Lipton SA. Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Arch Ophthalmol 1996; 114(3): 299-305.
60. Honkanen RA, Baruah S, Zimmerman MB, Khanna CL, Weaver YK, Narkiewicz J et al. Vitreous amino acid concentrations in patients with glaucoma undergoing vitrectomy. Arch Ophthalmol 2003; 121(2): 183-188.
61. Carter-Dawson L, Crawford ML, Harwerth RS, Smith EL, Feldman R, Shen FF et al. Vitreal glutamate concentration in monkeys with experimental glaucoma. Invest Ophthalmol Vis Sci 2002; 43(8): 2633-2637.
62. Santiago AR, Garrido MJ, Cristovao AJ, Duarte JM, Carvalho RA, Ambrosio AF. Evaluation of the impact of diabetes on retinal metabolites by NMR spectroscopy. Curr Eye Res 2010; 35: 992-1001.
63. Young SP, Nessim M, Falciani F, Trevino V, Banerjee SP, Scott RA et al. Metabolomic analysis of human vitreous humor differentiates ocular inflammatory disease. Mol Vis 2009; 15: 1210-1217.
64. Barba I, Garcia-Ramírez M, Hernández C, Alonso MA, Masmiquel L, García-Dorado D et al. Metabolic fingerprints of proliferative diabetic retinopathy: an 1H-NMR-based metabonomic approach using vitreous humor. Invest Ophthalmol Vis Sci 2010; 51(9): 4416-4421.
65. Li X, Luo X, Lu X, Duan J, Xu G. Metabolomics study of diabetic retinopathy using gas chromatography-mass spectrometry: a comparison of stages and subtypes diagnosed by Western and Chinese medicine. Mol Biosyst 2011; 7(7): 2228-2237.
66. Li M, Li H, Jiang P, Liu X, Xu D, Wang F. Investigating the pathological processes of rhegmatogenous retinal detachment and proliferative vitreoretinopathy with metabolomics analysis. Mol Biosyst 2014; 10(5): 1055-1062.
67. Ugarte M, Brown M, Hollywood KA, Cooper GJ, Bishop PN, Dunn WB. Metabolomic analysis of rat serum in streptozotocin-induced diabetes and after treatment with oral triethylenetetramine (TETA). Genome Med 2012; 4(4): 35.
68. Leino M, Airaksinen MM. Methoxyindoles of the retina. Med Biol 1985; 63(4): 160-169.
69. Guo J, Yan T, Bi H, Xie X, Wang X, Guo D et al. Plasma metabonomics study of the patients with acute anterior uveitis based on ultra-performance liquid chromatographymass spectrometry. Graefes Arch Clin Exp Ophthalmol 2014; 252(6): 925-934.
70. Osborn MP, Park Y, Parks MB, Burgess LG, Uppal K, Lee K et al. Metabolome-wide association study of neovascular age-related macular degeneration. PLoS One 2013; 8(8): e72737.
71. Pushpot S, Fitzpatrick M, Young S, Yang Y, Talks J, Wallace G. Metabolomic analysis in patients with age related macular degeneration. Invest Ophthalmol Vis Sci 2013; 54: (e-abstract 3662).
72. Agudo-Barriuso M, Lahoz A, Nadal-Nicolás FM, Sobrado-Calvo P, Piquer-Gil M, Díaz-Llopis M et al. Metabolomic changes in the rat retina after optic nerve crush. Invest Ophthalmol Vis Sci 2013; 54(6): 4249-4259.
73. Song Z, Gong Y, Liu H, Ren Q, Sun X. Glycyrrhizin could reduce ocular hypertension induced by triamcinolone acetonide in rabbits. Mol Vis 2011; 17(224): 2056-2064.
74. Kryczka T, Sel S, Wollensak G, Midelfart A. Metabolic profile of porcine corneas after photodynamic cross-linking treatment. Acta Ophthalmol 2012; 90(8): e658-e659